Developer docs
API playgroundTry for free, no card

Search company profiles

UMED Inc.

Full company profile

uuid00047t3

Namestring
UMED Inc.
Legal namestring
(주)유메드
Websiteurl
umedglobal.com
Company typeenum
Private
Founded yearint
2020
Descriptiontext

UMED Inc. (유메드) is a South Korea-based urologic healthcare platform founded in 2020 by Professor Park Myung-chan, a practicing urologist at Inje University Haeundae Paik Hospital. The company develops precision medical devices targeting catheter-associated urinary tract infections (CAUTI) and underserved urology patient populations, particularly the 80% of catheter patients who do not currently receive adequate bladder irrigation treatment. Its core product, UroRinse™ Light, is positioned as the world's first fully automated bladder irrigation system, using multi-sensor control technology to automate fluid inflow and outflow within a closed-system design that minimizes contamination risk. A secondary product line, UroAll® Solution, addresses urethral and bladder management through drug-eluting catheter technology developed in partnership with BioPlus.

The company's technology stack integrates the hardware devices with a connected digital health ecosystem spanning mobile applications, cloud databases, an AI-powered medical information chatbot, and symptom-analysis-based referral services. A September 2025 MOU with People & Technology extends this ecosystem via IoMT integration with the IndoorPlus+ SmartCare hospital platform, targeting EMR/HIS connectivity by 2027. UMED has secured Korean medical device manufacturing certification for UroRinse Light as of October 28, 2025, and is pursuing FDA and CE clearance for international expansion. Preclinical validation was published in the journal Urology (Gold Journal) in July 2025 through a collaboration with UCSD.

The business model centers on direct hardware sales to Korean hospitals and nursing facilities, with planned expansion into home care channels and future recurring revenue from digital platform subscriptions and AI-powered infection prevention services. GTM is primarily enterprise field sales to major Korean hospital groups including Asan Medical Center, Seoul National University Hospital, and several university hospitals, supported by participation in CES 2026 and acceleration programs (IBK창공, BTV Ventures). The company is venture-backed, with disclosed investors including Series Ventures, BTV Ventures, Widen Partners, Dream Ventures, and Busan United Holdings, alongside government grants. UMED operates from headquarters in Gimhae with additional offices in Busan and Ulsan, and currently has 1-10 employees.

Short descriptiontext

UMED Inc. is a South Korean urologic healthcare platform that has developed UroRinse™ Light, the world's first automated bladder irrigation system, targeting catheter-associated urinary tract infections. The company sells its devices to Korean hospitals and nursing facilities while pursuing FDA certification and digital health platform expansion.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersKimhae, South Korea
HQ citystring
Kimhae
HQ countrystring
South Korea
HQ regionstring
Asia
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
urology medical devices, automated bladder irrigation, catheter systems, infection prevention technology, digital health platform
Industry2 codes
PRIMARYHLAHALAI
Urinary Catheters & Drainage (Intermittent/Foley Catheters, Bags, Securement)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Wound Care, Ostomy & Continence Products
SECONDARYHLALAGAN
Urology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Surgical Appliance and Supplies Manufacturing339113
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Urology medical devices
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1UroRinse™ Light Sales
TypeHardware Sales
Description

Sale of automated bladder irrigation medical devices to hospitals, nursing facilities, and home care settings. The product received Korean medical device manufacturing certification on October 28, 2025. Plans to pursue FDA and CE certification for international sales.

prnewswire.com
2Digital Health Platform Services
TypeSubscription Recurring
Description

Future revenue stream from AI-powered infection prevention insights, remote monitoring services, and EMR integration through the connected digital health ecosystem.

finance.yahoo.com
3UroAll® Solution Catheter Products
TypeHardware Sales
Description

Sale of functional catheter systems for urology care, including drug-eluting catheters for urethral and bladder management.

umedglobal.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1UroRinse™ Light
Description

World's first automated bladder irrigation system - a smart medical device for automated and standardized bladder irrigation to reduce catheter-associated urinary tract infections.

umedglobal.com
+1 more record
Core offering1 text field

UMED Inc. develops and sells urology medical devices for hospitals, nursing facilities, and home care settings. Its flagship UroRinse™ Light is the world's first fully automated bladder irrigation system that uses multi-sensor technology and a closed-circuit design to standardize catheter flushing and reduce catheter-associated urinary tract infections. The company also offers the UroAll® Solution drug-eluting catheter system and is building a connected digital urology healthcare platform with mobile apps, cloud data, AI-powered medical information services, and EMR/IoMT integration.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • CAUTI prevention effectiveness validated through preclinical study published in Urology journal (Gold Journal)
+4 more records
Product overview1 text field

UMED Inc. offers a portfolio of urology medical devices and an AI-powered digital health platform. The core products are UroRinse™ Light, the world's first automated bladder irrigation system with sensor-based automation and closed-system design, and UroAll® Solution, a specialized functional catheter system. These devices are integrated into a broader digital urology platform that includes mobile apps, cloud databases, AI-powered medical information services with chatbot Q&A, and AI-driven symptom analysis for medical referrals and telemedicine connectivity. The platform aims to shift urology care from treatment-centered to prevention-centered paradigms.

Product and service2 records
1UroRinse™ Light
CategoryAutomated bladder irrigation medical device
Description

World's first fully automated bladder irrigation system that uses sensor-based automation and a closed-circuit design to standardize catheter flushing for hospitals, nursing facilities, and home care settings, targeting catheter-associated urinary tract infection (CAUTI) prevention.

2UroAll® Solution
CategoryUrology catheter system
Description

Functional drug-eluting catheter system specialized for urethral and bladder management, designed to improve patient quality of life and clinical utility for urology patients.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
1People & Technology (피플앤드테크놀러지)
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-08-20
Description

Strategic MOU for urology medical IoMT cooperation. Jointly developing smart medical service platform that integrates UMED's urology smart devices with hospital information systems by 2027. People & Technology's IndoorPlus+ SmartCare platform (BLE-based sensors for patient/medical device location and vital data monitoring) will connect with UMED devices, enabling real-time procedure data viewing by medical staff and smart clinical environment.

umedglobal.com
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-10-26
Description

MOU for joint research on urethral stricture medical devices. Development of drug-eluting catheter and anti-adhesion agent (Interblock) for urethral reconstruction. BioPlus provides anti-adhesion technology for urology application expansion.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Major Korean hospital partner for clinical trials and product validation of UroRinse™ Light automated bladder irrigation system.

4Seoul National University Hospital (SNUH, 서울대학교병원)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partner hospital for clinical trials and product development of urology medical devices.

umedglobal.com
5Ulsan University Hospital (울산대학교병원)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partner hospital for clinical trials and product development, also supporting company's Ulsan expansion plans.

umedglobal.com
6University of California San Diego (UCSD)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Joint research partner for preclinical studies of UroRinse™. Collaborative study published in Urology journal demonstrated effectiveness in CAUTI prevention. Led by Professor Mahadevan Raj Rajasekaran.

umedglobal.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Operating partner for Gyeongnam Startup Accelerating program (2023-2025). Provided 3 billion KRW in direct investment to program participants including UMED, organized global expansion programs including Singapore roadshow to SWITCH exhibition, and facilitated connections with ATUM Ventures, A*STAR, NUS, NTU, Infineon.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Corporate collaboration through 2024 Startup Growth Package program. UMED presented collaboration achievements with Samsung Heavy Industries during program成果 sharing event.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global medical products company with continence care and ostomy franchises including catheter-based products. Comparable as a broad incumbent addressing catheterized patient care.

TypeBroad incumbent
Description

US-based manufacturer of ostomy, continence, and critical care products including urinary drainage catheters. Comparable as a competing medical-device incumbent serving the same hospital and home-care urology/continence customers.

TypeBroad incumbent
Description

Danish global leader in ostomy, continence, and wound care, including a substantial urology catheter portfolio. Directly comparable as a competitor in urinary catheters and bladder management devices that UMED addresses via UroRinse Light and UroAll.

TypeBroad incumbent
Description

Global medical technology company with a substantial urology and infection-prevention portfolio. Comparable as a large incumbent that could enter automated bladder irrigation or supply competing catheter-based systems.

5Cook Medical
TypeBroad incumbent
Description

US-based privately held medical device company with a urology division offering catheter, stent, and drainage products. Comparable as a broad medical-device incumbent with overlapping urology product lines.

TypeDirect peer
Description

Medical device company with a focused urology franchise (e.g., Rusch, Urocare) including urinary catheters and drainage products. Most directly comparable as a catheter and urology-device specialist competing for the same clinical customers.

TypeEmerging player
Description

Specialty urology company developing drug-delivery and therapeutic solutions for urologic conditions, including drug-eluting technologies for bladder and urothelial disease. Comparable as an emerging specialist with overlapping drug-eluting catheter/urology focus similar to UMED's UroAll.

TypeDirect peer
Description

Specialist urology and continence care company (LoFric catheters, Navina) acquired by Investor AB. Comparable as a focused direct peer in catheter and bladder-management products with strong clinical evidence positioning similar to UMED's.

TypeBroad incumbent
Description

Global medical and pharmaceutical device company with a urology and continence care portfolio including catheter systems. Comparable as a large multi-category medical-device competitor serving the same hospital customer base.

TypeEmerging player
Description

Venture-backed medical device company developing catheter-based technologies for urological conditions such as kidney stones. Comparable as an emerging player attacking legacy catheter-based urology workflows with novel device approaches, similar to UMED's automation thesis.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

UMED Inc.

Urology medical devicesumedglobal.com

UMED Inc. is a South Korean urologic healthcare platform that has developed UroRinse™ Light, the world's first automated bladder irrigation system, targeting catheter-associated urinary tract infections. The company sells its devices to Korean hospitals and nursing facilities while pursuing FDA certification and digital health platform expansion.

What UMED Inc. does

UMED Inc. (유메드) is a South Korea-based urologic healthcare platform founded in 2020 by Professor Park Myung-chan, a practicing urologist at Inje University Haeundae Paik Hospital. The company develops precision medical devices targeting catheter-associated urinary tract infections (CAUTI) and underserved urology patient populations, particularly the 80% of catheter patients who do not currently receive adequate bladder irrigation treatment. Its core product, UroRinse™ Light, is positioned as the world's first fully automated bladder irrigation system, using multi-sensor control technology to automate fluid inflow and outflow within a closed-system design that minimizes contamination risk. A secondary product line, UroAll® Solution, addresses urethral and bladder management through drug-eluting catheter technology developed in partnership with BioPlus.

The company's technology stack integrates the hardware devices with a connected digital health ecosystem spanning mobile applications, cloud databases, an AI-powered medical information chatbot, and symptom-analysis-based referral services. A September 2025 MOU with People & Technology extends this ecosystem via IoMT integration with the IndoorPlus+ SmartCare hospital platform, targeting EMR/HIS connectivity by 2027. UMED has secured Korean medical device manufacturing certification for UroRinse Light as of October 28, 2025, and is pursuing FDA and CE clearance for international expansion. Preclinical validation was published in the journal Urology (Gold Journal) in July 2025 through a collaboration with UCSD.

The business model centers on direct hardware sales to Korean hospitals and nursing facilities, with planned expansion into home care channels and future recurring revenue from digital platform subscriptions and AI-powered infection prevention services. GTM is primarily enterprise field sales to major Korean hospital groups including Asan Medical Center, Seoul National University Hospital, and several university hospitals, supported by participation in CES 2026 and acceleration programs (IBK창공, BTV Ventures). The company is venture-backed, with disclosed investors including Series Ventures, BTV Ventures, Widen Partners, Dream Ventures, and Busan United Holdings, alongside government grants. UMED operates from headquarters in Gimhae with additional offices in Busan and Ulsan, and currently has 1-10 employees.

UMED Inc. firmographics

Firmographics
Name
UMED Inc.
Legal name
(주)유메드
Website
https://umedglobal.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
1–10 employees
Short description
UMED Inc. is a South Korean urologic healthcare platform that has developed UroRinse™ Light, the world's first automated bladder irrigation system, targeting catheter-associated urinary tract infections. The company sells its devices to Korean hospitals and nursing facilities while pursuing FDA certification and digital health platform expansion.
Ownership category
akta.pro rank

UMED Inc. industry classification

Industry
Product category
Urology medical devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical Appliance and Supplies Manufacturing (339113)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHALAI
Urinary Catheters & Drainage (Intermittent/Foley Catheters, Bags, Securement)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Wound Care, Ostomy & Continence Products
SECONDARYHLALAGAN
Urology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)

Keywords

  • Urology medical devices
  • Automated bladder irrigation
  • Catheter systems
  • Infection prevention technology
  • Digital health platform

Where UMED Inc. is headquartered

Location

Headquarters

HQ city
Kimhae
HQ country
South Korea
HQ region
Asia

Offices3 records

Markets served

UMED Inc. business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales

Revenue model

  1. UroRinse™ Light Sales: Sale of automated bladder irrigation medical devices to hospitals, nursing facilities, and home care settings. The product received Korean medical device manufacturing certification on October 28, 2025. Plans to pursue FDA and CE certification for international sales.
  2. Digital Health Platform Services: Future revenue stream from AI-powered infection prevention insights, remote monitoring services, and EMR integration through the connected digital health ecosystem.
  3. UroAll® Solution Catheter Products: Sale of functional catheter systems for urology care, including drug-eluting catheters for urethral and bladder management.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

UMED Inc. product offering

Product offering

Core offering

UMED Inc. develops and sells urology medical devices for hospitals, nursing facilities, and home care settings. Its flagship UroRinse™ Light is the world's first fully automated bladder irrigation system that uses multi-sensor technology and a closed-circuit design to standardize catheter flushing and reduce catheter-associated urinary tract infections. The company also offers the UroAll® Solution drug-eluting catheter system and is building a connected digital urology healthcare platform with mobile apps, cloud data, AI-powered medical information services, and EMR/IoMT integration.

Product overview

UMED Inc. offers a portfolio of urology medical devices and an AI-powered digital health platform. The core products are UroRinse™ Light, the world's first automated bladder irrigation system with sensor-based automation and closed-system design, and UroAll® Solution, a specialized functional catheter system. These devices are integrated into a broader digital urology platform that includes mobile apps, cloud databases, AI-powered medical information services with chatbot Q&A, and AI-driven symptom analysis for medical referrals and telemedicine connectivity. The platform aims to shift urology care from treatment-centered to prevention-centered paradigms.

Differentiator

Problem solved

Functional benefit

Brands

  • UroRinse™ Light: World's first automated bladder irrigation system - a smart medical device for automated and standardized bladder irrigation to reduce catheter-associated urinary tract infections.
  • UroAll® Solution

Products and services

  • UroRinse™ Light World's first fully automated bladder irrigation system that uses sensor-based automation and a closed-circuit design to standardize catheter flushing for hospitals, nursing facilities, and home care settings, targeting catheter-associated urinary tract infection (CAUTI) prevention.
  • UroAll® Solution Functional drug-eluting catheter system specialized for urethral and bladder management, designed to improve patient quality of life and clinical utility for urology patients.

Quantifiable outcome

  • CAUTI prevention effectiveness validated through preclinical study published in Urology journal (Gold Journal)
  • +4 more outcomes

Companies that use UMED Inc.

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles2 records

UMED Inc. technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature4 records

UMED Inc. partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and minor.

  • People & Technology (피플앤드테크놀러지)coreTechnology or Integration · 20 August 2025Strategic MOU for urology medical IoMT cooperation. Jointly developing smart medical service platform that integrates UMED's urology smart devices with hospital information systems by 2027. People & Technology's IndoorPlus+ SmartCare platform (BLE-based sensors for patient/medical device location and vital data monitoring) will connect with UMED devices, enabling real-time procedure data viewing by medical staff and smart clinical environment.
  • BioPlus (바이오플러스)minorStrategic or Co-development Partner · 26 October 2021MOU for joint research on urethral stricture medical devices. Development of drug-eluting catheter and anti-adhesion agent (Interblock) for urethral reconstruction. BioPlus provides anti-adhesion technology for urology application expansion.
  • Asan Medical Center (서울아산병원)coreStrategic or Co-development PartnerMajor Korean hospital partner for clinical trials and product validation of UroRinse™ Light automated bladder irrigation system.
  • Seoul National University Hospital (SNUH, 서울대학교병원)coreStrategic or Co-development PartnerPartner hospital for clinical trials and product development of urology medical devices.
  • Ulsan University Hospital (울산대학교병원)coreStrategic or Co-development PartnerPartner hospital for clinical trials and product development, also supporting company's Ulsan expansion plans.
  • University of California San Diego (UCSD)coreStrategic or Co-development PartnerJoint research partner for preclinical studies of UroRinse™. Collaborative study published in Urology journal demonstrated effectiveness in CAUTI prevention. Led by Professor Mahadevan Raj Rajasekaran.
  • BTV Ventures (비티비벤처스)coreStrategic or Co-development PartnerOperating partner for Gyeongnam Startup Accelerating program (2023-2025). Provided 3 billion KRW in direct investment to program participants including UMED, organized global expansion programs including Singapore roadshow to SWITCH exhibition, and facilitated connections with ATUM Ventures, A*STAR, NUS, NTU, Infineon.
  • Samsung Heavy Industries (삼성중공업)minorStrategic or Co-development PartnerCorporate collaboration through 2024 Startup Growth Package program. UMED presented collaboration achievements with Samsung Heavy Industries during program成果 sharing event.

Scale indicators7 records

Recent moves6 records

Expansion highlights7 records

UMED Inc. competitors and assessment

Company assessment

Broad incumbents

  • Convatec: Global medical products company with continence care and ostomy franchises including catheter-based products. Comparable as a broad incumbent addressing catheterized patient care.
  • Hollister Incorporated: US-based manufacturer of ostomy, continence, and critical care products including urinary drainage catheters. Comparable as a competing medical-device incumbent serving the same hospital and home-care urology/continence customers.
  • Coloplast: Danish global leader in ostomy, continence, and wound care, including a substantial urology catheter portfolio. Directly comparable as a competitor in urinary catheters and bladder management devices that UMED addresses via UroRinse Light and UroAll.
  • Becton, Dickinson and Company (BD): Global medical technology company with a substantial urology and infection-prevention portfolio. Comparable as a large incumbent that could enter automated bladder irrigation or supply competing catheter-based systems.
  • Cook Medical: US-based privately held medical device company with a urology division offering catheter, stent, and drainage products. Comparable as a broad medical-device incumbent with overlapping urology product lines.
  • B. Braun: Global medical and pharmaceutical device company with a urology and continence care portfolio including catheter systems. Comparable as a large multi-category medical-device competitor serving the same hospital customer base.

Direct peers

  • Teleflex Incorporated: Medical device company with a focused urology franchise (e.g., Rusch, Urocare) including urinary catheters and drainage products. Most directly comparable as a catheter and urology-device specialist competing for the same clinical customers.
  • WellSPECT Healthcare (formerly Astra Tech): Specialist urology and continence care company (LoFric catheters, Navina) acquired by Investor AB. Comparable as a focused direct peer in catheter and bladder-management products with strong clinical evidence positioning similar to UMED's.

Emerging players

  • UroGen Pharma: Specialty urology company developing drug-delivery and therapeutic solutions for urologic conditions, including drug-eluting technologies for bladder and urothelial disease. Comparable as an emerging specialist with overlapping drug-eluting catheter/urology focus similar to UMED's UroAll.
  • Calyxo (and other catheter-disruption startups): Venture-backed medical device company developing catheter-based technologies for urological conditions such as kidney stones. Comparable as an emerging player attacking legacy catheter-based urology workflows with novel device approaches, similar to UMED's automation thesis.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

UMED Inc. compliance and trust

Trust signal

Compliance1 record

UMED Inc. financial estimates

Financial estimate

Revenue estimate

Valuation estimate

UMED Inc. leadership team

Management profile

Number of profiles

Profiles1 record

UMED Inc. funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

UMED Inc. M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about UMED Inc.

What does UMED Inc. do?

UMED Inc. develops and sells urology medical devices for hospitals, nursing facilities, and home care settings. Its flagship UroRinse™ Light is the world's first fully automated bladder irrigation system that uses multi-sensor technology and a closed-circuit design to standardize catheter flushing and reduce catheter-associated urinary tract infections. The company also offers the UroAll® Solution drug-eluting catheter system and is building a connected digital urology healthcare platform with mobile apps, cloud data, AI-powered medical information services, and EMR/IoMT integration.

Is UMED Inc. a public or private company?

UMED Inc. is a private company. It is classified as venture growth investor backed and is currently operating.

When was UMED Inc. founded?

UMED Inc. was founded in 2020. It employs 1 to 10 people.

Where is UMED Inc. based?

UMED Inc. is headquartered in Kimhae, South Korea, in the Asia region.

How does UMED Inc. make money?

Three revenue lines are on record. UroRinse™ Light Sales are the primary driver. The others are digital Health Platform Services and uroAll® Solution Catheter Products.

Who are UMED Inc.'s main competitors?

Broad incumbents on record are Convatec, Hollister Incorporated, Coloplast, Becton, Dickinson and Company (BD), Cook Medical and B. Braun. Direct peers are Teleflex Incorporated and WellSPECT Healthcare (formerly Astra Tech). Emerging players are UroGen Pharma and Calyxo (and other catheter-disruption startups).

Does UMED Inc. have an API?

No public API is recorded for UMED Inc..

What industry is UMED Inc. in?

UMED Inc.'s product category is Urology medical devices. Its primary akta.pro industry code is HLAHALAI, Urinary Catheters & Drainage (Intermittent/Foley Catheters, Bags, Securement), with a secondary code of HLALAGAN, Urology Telemedicine Platforms. Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals